Cavernous hemangioma of the third ventricle: a case report and review of the literature by unknown
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Han et al. World Journal of Surgical Oncology 2014, 12:237
http://www.wjso.com/content/12/1/237CASE REPORT Open AccessCavernous hemangioma of the third ventricle: a
case report and review of the literature
Moon-Soo Han1, Kyung-Sub Moon1*, Kyung-Hwa Lee2, Seul-Kee Kim3 and Shin Jung1Abstract
Background: Although cavernous hemangiomas (CHs) can be found anywhere in the central nervous system,
CHs of the third ventricle have been reported in only 29 patients (including our case). In the current case report,
we discuss the clinical characteristics and surgical outcome of CHs of the third ventricle.
Case presentation: A 64-year-old female was admitted to our emergency room with a sudden decreased level
of consciousness. Brain imaging studies demonstrated a multi-lobulated hemorrhagic mass in the third ventricle.
The lesion was removed via the transcallosal-interforniceal approach and pathologically diagnosed as CH.
Postoperatively, the patient had a transient neurological deficit due to hypothalamic injury and recovered to the
normal status at 2 months after the operation. In the review of 29 cases, the mean age of the patients was
40 years with a slight female preponderance (female/male, 17/12). The majority of the patients complained of a
mass effect with signs of increased intracranial pressure; only one case was asymptomatic. Gross total resection
was achieved in 81% of the cases. Around 80% of the patients were asymptomatic or improved from the initial
symptoms. Mortality rate was 6.9% and the most common complication was hydrocephalus.
Conclusions: As demonstrated in the review of the previous reports, the outcome is favorable after surgical
excision for CH of the third ventricle. Hence, surgical excision appears to be the treatment of choice for CH
located in the third ventricle, which tends to grow rapidly resulting in a mass effect.
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Cavernous hemangiomas (cavernomas, cavernous angi-
omas, cavernous malformations; CH) are vascular
hamartomas that are reported to be found at any loca-
tion in the central nervous system (CNS). Due to the
increased use of computerized tomography (CT) scan
and magnetic resonance imaging (MRI), more CHs have
been diagnosed in recent years. However, intraventricular
location of CHs is uncommon, and the incidence of intra-
ventricular CHs has been reported to be only about 2.5 to
10.8% of all intracranial CHs [1,2]. The most frequent loca-
tion of intraventricular CHs is the lateral ventricle and in-
volvement of the third ventricle is quite rare. Based on the* Correspondence: moonks@chonnam.ac.kr
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unless otherwise stated.review of Medline database (PubMed, http://www.ncbi.nlm.
nih.gov/PubMed), only 29 cases (including our case) of CH
of the third ventricle have been reported [3-20].
We present the case of a patient who had a CH in the
third ventricle that was resected through the trans-
callosal interforniceal approach. In addition, we also re-
view the previously reported cases and discuss their
clinical characteristics and surgical outcomes.
Case presentation
A 64-year-old female was admitted to our emergency
room with a sudden decreased level of consciousness.
Except for an intermittent and mild degree headache,
there was no specific history of head trauma and me-
dical illness. On neurological examination, she showed a
drowsy mentality with Glasgow Coma Scale score of
14/15 and the right homonymous hemianopsia. She did not
have motor/sensory and cranial nerve deficits, and cerebel-
lar signs. There were no abnormal laboratory findings.
Non-contrasted CT scan showed a heterogeneously. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Axial non-contrast CT images show a large and
heterogeneously hyperattenuated hemorrhagic mass in the
suprasellar area, with dilatation of the anterior part of the third
ventricle (arrow).
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http://www.wjso.com/content/12/1/237hyperattenuated hemorrhagic mass within the third ven-
tricle compressing the hypothalamus, without definitive
hydrocephalus (Figure 1). Brain MRI revealed a 40 × 30 ×
28 mm sized multi-lobulated mass with a recent
hemorrhage in the third ventricle, which extended to the
foramen of Monro and hypothalamus. There was no defi-
nite contrast enhancement (Figure 2).
Right-side interhemispheric, transcallosal interforniceal
approach was used for removal of the lesion. At surgery,
the lesion was found to be a red colored, multi-lobulatedFigure 2 Preoperative MRI images. Sagittal T1-weighted (A) and post-co
mass in the anterior third ventricle and hypothalamic area. Axial T1-weig
demonstrate a typical cavernous malformation with heterogeneous sign
stage hemorrhage.mass, which had numerous vascular channels and multi-
staged hemorrhage. Although there were severe adhe-
sions between the base of the lesion and the basilar
arterial system, gross total removal of the lesion was
possible due to the presence of the discrete sticky hemo-
siderin rim, which allowed differentiation of the lesion
from the surrounded normal parenchyma (Figure 3). To
prevent hypothalamic injury, the resection of hemosiderin-
stained tissue was restricted to the minimum.
Histopathological examination of the lesion revealed a
CH composed of large, irregularly dilated, blood-filled
vascular channels lined by flat endothelium (Figure 4).
Postoperatively, the patient developed transient diabetes
insipidus, somnolence, and general weakness due to hypo-
thalamic injury, but these symptoms gradually disappeared
with conservative treatment. Finally, she recovered to the
normal status at 2 months after the operation.
Discussion
CHs are vascular hamartomas which are reported to be
found anywhere in the CNS. However, intraventricular
CHs are rare and their incidence was reported to be only
about 2.5 to 10.8% of all cerebral cavernous malforma-
tions [1,2]. CHs may be diagnosed based on symptoms
of acute hemorrhage, seizures, or progressive neurologic
deficits. Chadduck et al. [21] reported that there was nontrast T1-weighted (B) images show a non-enhancing hemorrhagic
hted (C), T2-weighted (D), and susceptibility weighted (E) images
al intensity and hemosiderin rim indicating mixed acute or subacute
Figure 3 Intraoperative photographs through transcallosal interforniceal approach. (A) After dissection of the corpus callosum, the
interforniceal plane (asterisk) was observed between the bilateral septum pallucidum; (B) After entering the third ventricle via the interforniceal
approach, a red-colored and multi-lobulated cavernous hemangioma with numerous vascular channels and different-staged hemorrhage was
encountered; (C and D) Removal of the lesion revealed the patency of the Sylvian aqueduct (asterisk) over the massa intermedia and the basilar
system in the base of the lesion.
Figure 4 Pathologic findings of the cavernous hemangioma.
The microphotograph displayed a blood-filled lesion composed of
irregularly dilated channels and a slightly fibrotic capsule surrounding
the lesion (hematoxylin and eosin, original magnification × 100).
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http://www.wjso.com/content/12/1/237difference between the clinical symptoms and signs of
intraventricular CHs and parenchymal CHs. However,
because of the rarity, the natural history and clinical fea-
tures of CHs located in the third ventricle have not been
fully investigated and there are no definite recommenda-
tions for its management.
Overall, 29 patients with a well-described CH in the
third ventricle have been reported in the literature, in-
cluding our case [3-20] (Table 1), with a slight female
preponderance (female/male ratio, 58/42%). The median
age of the patients was 40 years (range, 8–64 years) and
6 patients were of the pediatric age group (21%). The
most frequent initial clinical symptoms included a mass
effect, with signs of increased intracranial pressure (head-
ache, nausea, vomiting, visual disturbance, memory
impairment and signs of hypothalamic dysfunction) in
23 patients (79%). Intraventricular hemorrhage from
the lesion occurred in 3 cases (10%) and seizures in 2
cases (7%); only one patient was asymptomatic. This
higher incidence of mass effect symptoms may be be-
cause of the direct compression of the surrounding
Table 1 Summarized surgically resected cavernous hemangioma of the third ventricle
Authors Publication year Age
(year)




Vaquero et al. [3] 1980 18 F Diplopia – TC GTR Improved
Pozzati et al. [4] 1980 31 F Headache, vomiting – TV GTR Improved
Lavyne et al. [5] 1983 48 F Headache, memory impairment 1.5 TC + TV + SC PR Not improved HDC, IVH
Amagasa et al. [6] 1984 40 M Homonymous hemianopsia,
endocrine function deficit
– IH + TLT GTR Improved
Harbaugh et al. [7] 1984 44 F Headache, vomiting, IVH 2 TC + TV GTR Improved HDC
Yamasaki et al. [8] 1986 9 M Headache 2.5 – GTR Improved
15 F Lower temporal quadrantopsia 1.5 – PR No symptom
36 M Headache, vomiting,
mental change
2.5 – PR Improved
Voci et al. [9] 1989 19 F IVH – TC GTR Improved
Ogawa et al. [10] 1990 16 M Headache, nausea 2 IH + TLT GTR No symptom
40 M Homonymous hemianopsia,
endocrine function deficit
2 IH + TLT GTR Improved
Katayama et al. [11] 1994 9 F Seizure – IH + TLT PR Death
50 F – – – – Improved
45 F IVH – – – Not improved Vegetative state
49 M Visual field defect, endocrine
function deficit
2 – – Improved
47 F Memory impairment 3 SC + TVI GTR Improved Transient DI, Recurrence
Sinson et al. [12] 1995 43 F Headache, memory impairment 3 IH + TC + IF GTR Death
36 F Memory impairment, weight gain 3 IH + TC + IF GTR Not improved HDC
52 F Headache, nausea 3.5 TCo GTR Improved
32 F Headache, vomiting, diplopia 2 IFT + SCbll GTR Improved
Reyns et al. [13] 1999 42 M Seizure 2.5 TCo + TVI PR Improved Recurrence
Crivell et al. [14] 2002 38 M Memory impairment, gait
disturbance, headache, vomiting
– TCo + TVI GTR Improved
Wang et al. [15] 2003 62 F Gait disturbance – TCo + TV GTR Not improved ICH on thalamus,
CNS infection
Milenkovic et al. [16] 2005 56 M Headache, memory impairment,
bizarre behavior
– TC + TV + TF GTR Improved
Darwish et al. [17] 2005 47 F No symptom 1.5 TC + TV + TF GTR No symptom HDC




















Table 1 Summarized surgically resected cavernous hemangioma of the third ventricle (Continued)
Zakaria et al. [19] 2006 8 M Headache, vomiting,
gait disturbance
– TC GTR Improved
Kivelev et al. [20] 2010 52 M Headache, vomiting – TC + IF(?) GTR Improved
Present study 2012 64 F Mental change, homonymous
hemianopsia
4 TC + IF GTR Improved Transient DI & hypothalamic
injury symptoms*
*; totally resolved at 2 months after the operation.
–, not available; DI, Diabetes insipidus; F, Female; GTR, Gross total resection; HDC, Hydrocephalus; ICH, Intracerebral hemorrhage; IF, Interforniceal; IH, Interhemisphric; IFT, Infratentorial; IVH, Intraventricular hemorrhage;
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http://www.wjso.com/content/12/1/237structures, due to CH growth. Katayama et al. [5] stated
that intraventricular CHs tend to grow rapidly resulting in
giant malformation, because of low mechanical resistance
caused by lack of the surrounding brain tissue and repeated
hemorrhage in the CH. In the literature, the mean size of
the lesions was reported to be 23 mm (range, 12–40 mm).
Although intralesional bleeding can frequently occur when
CHs grow within the ventricle, bleeding from a CH
into the ventricular system is rare as per the previous
reports [10].
The radiological findings of the intraventricular CHs do
not differ from those of the intraparenchymal type [10].
Generally, on CT scans, the CH is suggested by the pres-
ence of a high density area, absence of perilesional edema,
and mild or no contrast enhancement because of blood
pool effects, calcification, and recent hemorrhage [22]. On
MRI images, the CHs usually have mixed signal intensities.
High signal intensities correlate with the presence of
methemoglobin and low signal intensities correlate with
calcifications and fibrosis within the lesion on T1- and T2-
weighted images. A peripheral rim of low signal intensity
correlates with the paramagnetic effect of hemosiderin [23].
A conservative treatment is appropriate for an asymp-
tomatic CH located in the supratentorial parenchyma.
However, CHs located in the third ventricle, surrounded by
vital structures, are especially dangerous. It has also been
documented that these lesions show a rapid growth [5],
resulting in significant morbidity. For these reasons, the
third ventricular CH needs to be treated more aggressively.
As shown in Table 1, 80% of the patients were asymptom-
atic or improved from their initial symptoms after the
surgical procedure. The most frequent post-operative com-
plication was a hydrocephalus, observed in four patients.
Postoperative mortality was 6.9% (2/29). The important
point to be noted, as illustrated by our case, is that large-
sized lesions frequently involve the hypothalamus [6,10,11].
Therefore, careful dissection of the lesion should be
performed to prevent damage to the hypothalamus. To
reduce this complication, minimizing the resection of
hemosiderin-stained tissue and preservation of associated
developmental venous anomalies are the key points, as in
surgery for CHs located in the brain stem or cranial nerves
[24,25]. Furthermore, during the operation for CHs buried
in the parenchyma with a critical neurological function,
initial dissection and removal of the lesion should be
attempted on the short trajectory after observation of the
surface changes caused by the hemorrhage [24,26].
Considering these principles, transcallosal-interforniceal
approach can provide a direct, short corridor to the third
ventricle with wide exposure of the lesion.
Conclusions
Surgical excision appears to be the treatment of choice
for CHs located in the third ventricle, which tend togrow rapidly and cause a mass effect. Using the short
corridor to the third ventricle, obtaining wide exposure
of the lesion, and minimizing resection of the surround-
ing hemosiderin-stained tissue can lead to a favorable
surgical outcome, as demonstrated in the previous
reports, including this report.
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